On the basis of these findings, we hypothesized that chemotherapy enhances cancer-cell-derived GM-CSF expression, which activates TAM-derived SPP1 and, in turn, induces chemoresistance in cancer cells (Figure 4). The gene discussed is CSF2; the disease is cancer.